Retinal Biologics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Diabetic Macular Edema
1.2.5 Uveitis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Biologics Market Perspective (2017-2028)
2.2 Retinal Biologics Growth Trends by Region
2.2.1 Retinal Biologics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Retinal Biologics Historic Market Size by Region (2017-2022)
2.2.3 Retinal Biologics Forecasted Market Size by Region (2023-2028)
2.3 Retinal Biologics Market Dynamics
2.3.1 Retinal Biologics Industry Trends
2.3.2 Retinal Biologics Market Drivers
2.3.3 Retinal Biologics Market Challenges
2.3.4 Retinal Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Biologics Players by Revenue
3.1.1 Global Top Retinal Biologics Players by Revenue (2017-2022)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2017-2022)
3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Biologics Revenue
3.4 Global Retinal Biologics Market Concentration Ratio
3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2021
3.5 Retinal Biologics Key Players Head office and Area Served
3.6 Key Players Retinal Biologics Product Solution and Service
3.7 Date of Enter into Retinal Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Biologics Breakdown Data by Type
4.1 Global Retinal Biologics Historic Market Size by Type (2017-2022)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2023-2028)
5 Retinal Biologics Breakdown Data by Application
5.1 Global Retinal Biologics Historic Market Size by Application (2017-2022)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Retinal Biologics Market Size (2017-2028)
6.2 North America Retinal Biologics Market Size by Type
6.2.1 North America Retinal Biologics Market Size by Type (2017-2022)
6.2.2 North America Retinal Biologics Market Size by Type (2023-2028)
6.2.3 North America Retinal Biologics Market Share by Type (2017-2028)
6.3 North America Retinal Biologics Market Size by Application
6.3.1 North America Retinal Biologics Market Size by Application (2017-2022)
6.3.2 North America Retinal Biologics Market Size by Application (2023-2028)
6.3.3 North America Retinal Biologics Market Share by Application (2017-2028)
6.4 North America Retinal Biologics Market Size by Country
6.4.1 North America Retinal Biologics Market Size by Country (2017-2022)
6.4.2 North America Retinal Biologics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Retinal Biologics Market Size (2017-2028)
7.2 Europe Retinal Biologics Market Size by Type
7.2.1 Europe Retinal Biologics Market Size by Type (2017-2022)
7.2.2 Europe Retinal Biologics Market Size by Type (2023-2028)
7.2.3 Europe Retinal Biologics Market Share by Type (2017-2028)
7.3 Europe Retinal Biologics Market Size by Application
7.3.1 Europe Retinal Biologics Market Size by Application (2017-2022)
7.3.2 Europe Retinal Biologics Market Size by Application (2023-2028)
7.3.3 Europe Retinal Biologics Market Share by Application (2017-2028)
7.4 Europe Retinal Biologics Market Size by Country
7.4.1 Europe Retinal Biologics Market Size by Country (2017-2022)
7.4.2 Europe Retinal Biologics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Biologics Market Size (2017-2028)
8.2 Asia-Pacific Retinal Biologics Market Size by Type
8.2.1 Asia-Pacific Retinal Biologics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Retinal Biologics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Retinal Biologics Market Share by Type (2017-2028)
8.3 Asia-Pacific Retinal Biologics Market Size by Application
8.3.1 Asia-Pacific Retinal Biologics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Retinal Biologics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Retinal Biologics Market Share by Application (2017-2028)
8.4 Asia-Pacific Retinal Biologics Market Size by Region
8.4.1 Asia-Pacific Retinal Biologics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Retinal Biologics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Biologics Market Size (2017-2028)
9.2 Latin America Retinal Biologics Market Size by Type
9.2.1 Latin America Retinal Biologics Market Size by Type (2017-2022)
9.2.2 Latin America Retinal Biologics Market Size by Type (2023-2028)
9.2.3 Latin America Retinal Biologics Market Share by Type (2017-2028)
9.3 Latin America Retinal Biologics Market Size by Application
9.3.1 Latin America Retinal Biologics Market Size by Application (2017-2022)
9.3.2 Latin America Retinal Biologics Market Size by Application (2023-2028)
9.3.3 Latin America Retinal Biologics Market Share by Application (2017-2028)
9.4 Latin America Retinal Biologics Market Size by Country
9.4.1 Latin America Retinal Biologics Market Size by Country (2017-2022)
9.4.2 Latin America Retinal Biologics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Biologics Market Size (2017-2028)
10.2 Middle East & Africa Retinal Biologics Market Size by Type
10.2.1 Middle East & Africa Retinal Biologics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Retinal Biologics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Retinal Biologics Market Share by Type (2017-2028)
10.3 Middle East & Africa Retinal Biologics Market Size by Application
10.3.1 Middle East & Africa Retinal Biologics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Retinal Biologics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Retinal Biologics Market Share by Application (2017-2028)
10.4 Middle East & Africa Retinal Biologics Market Size by Country
10.4.1 Middle East & Africa Retinal Biologics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Retinal Biologics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Spark Therapeutics, Inc
11.1.1 Spark Therapeutics, Inc Company Details
11.1.2 Spark Therapeutics, Inc Business Overview
11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2017-2022)
11.1.5 Spark Therapeutics, Inc Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Regeneron Pharmaceuticals, Inc Company Details
11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2017-2022)
11.3.5 Regeneron Pharmaceuticals, Inc Recent Developments
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Details
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Retinal Biologics Introduction
11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2017-2022)
11.4.5 AbbVie Inc Recent Developments
11.5 Johnson & Johnson Services, Inc
11.5.1 Johnson & Johnson Services, Inc Company Details
11.5.2 Johnson & Johnson Services, Inc Business Overview
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2017-2022)
11.5.5 Johnson & Johnson Services, Inc Recent Developments
11.6 Amgen Inc
11.6.1 Amgen Inc Company Details
11.6.2 Amgen Inc Business Overview
11.6.3 Amgen Inc Retinal Biologics Introduction
11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2017-2022)
11.6.5 Amgen Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Diabetic Macular Edema
Table 5. Key Players of Uveitis
Table 6. Key Players of Others
Table 7. Global Retinal Biologics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Retinal Biologics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Retinal Biologics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Retinal Biologics Market Share by Region (2017-2022)
Table 11. Global Retinal Biologics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Retinal Biologics Market Share by Region (2023-2028)
Table 13. Retinal Biologics Market Trends
Table 14. Retinal Biologics Market Drivers
Table 15. Retinal Biologics Market Challenges
Table 16. Retinal Biologics Market Restraints
Table 17. Global Retinal Biologics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Retinal Biologics Revenue Share by Players (2017-2022)
Table 19. Global Top Retinal Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2021)
Table 20. Ranking of Global Top Retinal Biologics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Biologics Product Solution and Service
Table 24. Date of Enter into Retinal Biologics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Retinal Biologics Revenue Market Share by Type (2017-2022)
Table 28. Global Retinal Biologics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Retinal Biologics Revenue Market Share by Type (2023-2028)
Table 30. Global Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Retinal Biologics Revenue Share by Application (2017-2022)
Table 32. Global Retinal Biologics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Retinal Biologics Revenue Share by Application (2023-2028)
Table 34. North America Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Retinal Biologics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Retinal Biologics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Retinal Biologics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Retinal Biologics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Retinal Biologics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Retinal Biologics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Retinal Biologics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Retinal Biologics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Retinal Biologics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Retinal Biologics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Retinal Biologics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Retinal Biologics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Spark Therapeutics, Inc Company Details
Table 65. Spark Therapeutics, Inc Business Overview
Table 66. Spark Therapeutics, Inc Retinal Biologics Product
Table 67. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 68. Spark Therapeutics, Inc Recent Developments
Table 69. F. Hoffmann-La Roche Ltd Company Details
Table 70. F. Hoffmann-La Roche Ltd Business Overview
Table 71. F. Hoffmann-La Roche Ltd Retinal Biologics Product
Table 72. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 73. F. Hoffmann-La Roche Ltd Recent Developments
Table 74. Regeneron Pharmaceuticals, Inc Company Details
Table 75. Regeneron Pharmaceuticals, Inc Business Overview
Table 76. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
Table 77. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 78. Regeneron Pharmaceuticals, Inc Recent Developments
Table 79. AbbVie Inc Company Details
Table 80. AbbVie Inc Business Overview
Table 81. AbbVie Inc Retinal Biologics Product
Table 82. AbbVie Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 83. AbbVie Inc Recent Developments
Table 84. Johnson & Johnson Services, Inc Company Details
Table 85. Johnson & Johnson Services, Inc Business Overview
Table 86. Johnson & Johnson Services, Inc Retinal Biologics Product
Table 87. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 88. Johnson & Johnson Services, Inc Recent Developments
Table 89. Amgen Inc Company Details
Table 90. Amgen Inc Business Overview
Table 91. Amgen Inc Retinal Biologics Product
Table 92. Amgen Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
Table 93. Amgen Inc Recent Developments
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Share by Type: 2021 VS 2028
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Diabetic Macular Edema Features
Figure 5. Uveitis Features
Figure 6. Others Features
Figure 7. Global Retinal Biologics Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Biologics Report Years Considered
Figure 12. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Retinal Biologics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Retinal Biologics Market Share by Region: 2021 VS 2028
Figure 15. Global Retinal Biologics Market Share by Players in 2021
Figure 16. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2021
Figure 18. North America Retinal Biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Retinal Biologics Market Size Market Share by Type (2017-2028)
Figure 20. North America Retinal Biologics Market Size Market Share by Application (2017-2028)
Figure 21. North America Retinal Biologics Market Size Share by Country (2017-2028)
Figure 22. United States Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Retinal Biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Retinal Biologics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Retinal Biologics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Retinal Biologics Market Size Share by Country (2017-2028)
Figure 28. Germany Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Retinal Biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Retinal Biologics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Retinal Biologics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Retinal Biologics Market Size Share by Region (2017-2028)
Figure 38. China Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Retinal Biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Retinal Biologics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Retinal Biologics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Retinal Biologics Market Size Share by Country (2017-2028)
Figure 48. Mexico Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Retinal Biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Retinal Biologics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Retinal Biologics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Retinal Biologics Market Size Share by Country (2017-2028)
Figure 54. Turkey Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 59. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 60. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 61. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 62. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
